Press release
Atypical Antipsychotics to Lead Global Depression Drugs Market Through 2026 | Johnson and Johnson, GlaxoSmithKline, Novartis AG
The depression drugs market, valued at over US$ 6.5 billion in 2017, is likely to witness bearishness in the near future, with a new report by Fact.MR estimating revenues to decline at a -2% CAGR.Click here to Get Complete Synopsis of the Report - https://www.factmr.com/report/3215/depression-drugs-market
According to the study, although the prevalence rate of depression has gone up in the last decade, preference for cognitive behavior therapy (CBT) and awareness about the potential side effects has led to a decline in demand for depression drugs. The study finds that US continued to be at the forefront in terms of total depression drugs sold in 2018.
According to the World Health Organization (WHO), depression has become one of the common illnesses, affecting over 300 million people across the world. In the United States, approximately 10.3 million adults had experienced at least one major depressive episode that resulted in severe impairment, according to the National Institute of Mental Health (NIMH). High prevalence of such depressive episode was observed among people aged 18-25 (10.9%), female adults (8.5%), and male adults (4.8%).
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=3215
According to the Fact.MR study, although depression continues to be a major health issue, medical community and patients are encouraging a non-drug approach to reduce side effects and dependency. Healthcare providers and patients are focusing on cognitive behavior therapy (CBT) and mindfulness-based approaches to foster a long-term management of depression and other mental health issues.
Depression Drugs Market: Segment-wise Insights
• On the basis of drug class, the global depression drugs market has been segmented into SSRIs, atypical antipsychotics, SNRIs, CNS stimulants, and others. Of these, atypical antipsychotics is expected to contribute the largest share in the market.
• Major depressive disorder has been envisaged to account for the most substantial share in the depression drugs market based on disease type. Other sub-segments include SSRI induced, schizophrenia, and bipolar I disorder.
• While depression drugs are sold across retail, hospital, and online pharmacies, the retail segment registered the largest share in 2017, and the trend is expected to continue during the 2018-2026 period.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=3215
Depression Drugs Market to Remain Concentrated in Developed Nations
North America and Europe are the two largest depression drugs market globally, owing to concentration of leading market players and increase in R&D of these drugs. While there has been a rising burden of mental illness such as bipolar I disorder and schizophrenia in China and India, lack of wide-ranging awareness regarding antidepressant medications (ADMs) is expected to negatively affect the growth of depression drugs market in the Asia Pacific region.
Moreover, different therapies of depression are as efficacious as ADM and their effects are more enduring, which may create a hindrance in future expansion of depression drugs market, especially in Asia Pacific and Middle East & Africa.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/3215/S
Global Depression Drugs Market: Competitive Landscape
Some key players operating in the manufacturing of depression drugs are Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson, Sebela Pharmaceutical Inc., GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Allergan USA, Inc., Takeda Pharmaceutical Company Ltd, Novartis AG, Pfizer, Inc., Alkermes Plc, H. Lundbeck, Bristol Myers Squibb Co., and Teva Pharmaceutical Industries Ltd.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/3215/depression-drugs-market
Content Source: https://www.factmr.com/media-release/935/depression-drugs-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atypical Antipsychotics to Lead Global Depression Drugs Market Through 2026 | Johnson and Johnson, GlaxoSmithKline, Novartis AG here
News-ID: 2275154 • Views: …
More Releases from Fact.MR
Silicon Anode Slurries Market Forecast 2026-2036: Market Size, Share, Competitiv …
The global silicon anode slurries market is set for significant expansion between 2026 and 2036, fueled by the rising adoption of high-energy-density lithium-ion batteries across electric vehicles (EVs), consumer electronics, and grid-scale energy storage. As battery manufacturers increasingly transition from graphite to silicon-enhanced anodes, the demand for high-performance, scalable silicon anode slurries is projected to grow sharply.
To access the complete data tables and in-depth insights, request a Discount On The…
Silicon Anode Slurries Market Forecast 2026-2036: Market Size, Share, Competitiv …
The global silicon anode slurries market is set for significant expansion between 2026 and 2036, fueled by the rising adoption of high-energy-density lithium-ion batteries across electric vehicles (EVs), consumer electronics, and grid-scale energy storage. As battery manufacturers increasingly transition from graphite to silicon-enhanced anodes, the demand for high-performance, scalable silicon anode slurries is projected to grow sharply.
To access the complete data tables and in-depth insights, request a Discount On The…
Low-Siloxane Cleanroom Wall Coatings Market Deep-Dive 2026-2036: Strategic Forec …
The low-siloxane cleanroom wall coatings market is poised for steady growth over the next decade, driven by rising contamination-control requirements across semiconductor, pharmaceutical, biotechnology, and precision manufacturing industries. These coatings are specifically engineered to minimize siloxane outgassing and volatile organic compound emissions, helping maintain ultra-clean environments where even trace contamination can disrupt production quality.
By 2036, the market for low-siloxane cleanroom wall coatings is expected to grow to USD 91.04 million.…
Low-Siloxane Cleanroom Wall Coatings Market Deep-Dive 2026-2036: Strategic Forec …
The low-siloxane cleanroom wall coatings market is poised for steady growth over the next decade, driven by rising contamination-control requirements across semiconductor, pharmaceutical, biotechnology, and precision manufacturing industries. These coatings are specifically engineered to minimize siloxane outgassing and volatile organic compound emissions, helping maintain ultra-clean environments where even trace contamination can disrupt production quality.
By 2036, the market for low-siloxane cleanroom wall coatings is expected to grow to USD 91.04 million.…
More Releases for Unit
Global Transcutaneous Electrical Nerve Stimulation Unit Market, Transcutaneous E …
Global Transcutaneous Electrical Nerve Stimulation Unit Market Overview:
The Transcutaneous Electrical Nerve Stimulation Unit market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Transcutaneous Electrical Nerve Stimulation Unit market has experienced significant growth, driven by factors such as increasing consumer demand,…
Glycol Dehydration Unit Market Glycol Dehydration Unit Market 2028
Persistence Market Research delivers key insights on the global glycol dehydration unit market, in its report titled, 'Glycol Dehydration Unit Market: Global Industry Analysis 2013-2017 and Forecast 2018-2028'. Over the forecast years, the global glycol dehydration unit market is expected to show a positive outlook.
The market value is expected to increase at a healthy pace over the forecast period. Based on the glycol type segment, the triethylene glycol segment is…
Biodiesel Processing Unit
While reserves of petroleum are decreasing every passing day, energy consumption is increasing at 6.5% per annum. And for solving this issue many countries are implementing new policies for minimizing the usage of fossil fuels and increase the use of alternative sources like solar power and Biodiesel. Biodiesel is a diesel fuel substitute made from a variety of oils, fats, and greases which can become a cheaper alternative to fossil…
Jackfruit Processing Unit
The fruit processing sector has some undoubtedly potential Business Ideas, and Jackfruits processing is highly recommended because jackfruits are highly perishable tropical fruits, which helps in improving the immunity, replenishes the energy, cardiovascular health, regulates Blood Pressure, Digestion, treats the skin diseases, prevent/control asthma and many more awesome advantages of jackfruit consumption.
Rising demand for processed fruit product for secondary preparations, rising income, and resultant increased spending on food items is…
Pomegranate Processing unit
India is the second largest producer of Pomegranates in the world after Iran, still contributes only 5% pomegranate related international trades. India produces the finest edible Pomegranates, which are available almost throughout the year, which provides a tremendous potential for export of Pomegranate and its products from India.
Processing of the Pomegranates becomes essential in order to increase the utilization and reduce the wastage of the fruit. Pomegranates being rich in…
Coconut Processing Unit
Coconut is an important fruit in the Indian economy as the country is listed among the top Coconut producing countries in the world. The contribution of Coconut is about ₹27900 crore to India’s Gross Domestic Product (GDP).
Today's improved economic stability, spending power, nutritional requirements, and awareness are pushing consumers to shift their preferences.
Currently, Coconut water, Coconut milk/cream and Virgin Coconut Oil (VCO) are expected to be main growth drivers for…
